Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s First Chief Scientist Is Wake Forest Oncologist Frank Torti

Executive Summary

FDA's new Chief Scientist Frank Torti will be asked to concentrate on clinical research when he assumes the newly created position in May, FDA announced April 9

You may also be interested in...



FDA’s Von Eschenbach Returns To Texas In January; Will He Also Return To MD Anderson?

Von Eschenbach’s resignation is effective Jan. 20; FDA commissioner expresses hope that senior team will remain at least partly intact.

FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence

FDA's newly appointed Chief Scientific Officer Frank Torti will focus on collaborations with industry and academia in order to boost the agency's scientific expertise and augment scarce resources, he said at a May 30 Science Board Meeting

FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence

FDA's newly appointed Chief Scientific Officer Frank Torti will focus on collaborations with industry and academia in order to boost the agency's scientific expertise and augment scarce resources, he said at a May 30 Science Board Meeting

Related Content

UsernamePublicRestriction

Register

PS049506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel